HomeAIMDW • NASDAQ
add
Amarillo Biosciences
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.02M | 32.07% |
Net income | -3.20M | -35.97% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.85M | -68.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.01M | 488.85% |
Total assets | 35.54M | 4.39% |
Total liabilities | 14.83M | 306.10% |
Total equity | 20.71M | — |
Shares outstanding | 7.66M | — |
Price to book | 0.02 | — |
Return on assets | -23.35% | — |
Return on capital | -24.21% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -3.20M | -35.97% |
Cash from operations | -1.97M | -72.23% |
Cash from investing | -8.51K | -797.13% |
Cash from financing | 9.00M | 549.36% |
Net change in cash | 6.98M | 3,150.45% |
Free cash flow | -893.34K | -173.50% |
About
Founded
1984
Website
Employees
46